New research indicates that patients who come off new weight-loss injections like Wegovy and Mounjaro can put back on shed pounds far faster than those who end conventional diet and exercise plans.
Research printed in a major medical journal shows that while obese individuals frequently drop about a fifth of their total mass while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing these treatments must be aware of the danger of rapid rebound weight gain when the treatment is stopped," warns expert Dr. Susan Jebb.
This pace of regain implies a reversion to pre-treatment weight within about a year and a half.
Weighing Therapies
The analysis, which looked at dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with older methods.
Scientists emphasize that people who lose weight through diet and exercise generally experience a slower creep back—around 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Nutrition scientists believe the way of the jabs is key to understanding the amplified weight return.
The injections imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone levels several times higher than normal might result in the body to produce less of its own natural GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication leads to appetite is uncontrolled, making overeating far more likely."
A Lifelong Disease?
The NHS suggest the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts say that, considering the likelihood of weight regain, the therapy should be considered life-long.
This opinion is echoed by pharmaceutical companies, who note that the findings "underscore the persistent character of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
People who have stopped the jabs report a powerful return of cravings.
"It was like something flipping and I was suddenly extremely hungry," described an individual.
This difficulty is exacerbated if users have not developed lasting lifestyle or habit modifications during treatment.
Significant Use
Survey data indicate that millions of adults in the UK have used these injections in the past year, with demand remaining high.
- Adoption is higher among females compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a standalone fix and maintained weight loss likely depends on ongoing lifestyle support.
